passages.id: 1489
passages.type: sentence
passages.text: The end point of CALGB 8642 is to assess the difference in survival , toxicity , and overall response when limited exposure to Phase II agents precedes standard chemotherapy .
entities.id: 1490
entities.type: outcome
entities.text: assess the difference in survival , toxicity , and overall response